Entrada Therapeutics (TRDA) Receivables (2023 - 2026)
Entrada Therapeutics (TRDA) posted quarterly Receivables of $787000.0 for Q1 2026, down 61.5% year-over-year from $2.0 million in Q1 2025, and down 33.14% quarter-over-quarter from $1.2 million in Q4 2025.
Entrada Therapeutics (TRDA) Receivables (2023 - 2026) Analysis & Trends
Entrada Therapeutics' Receivables history runs 4 years deep, the most recent figure standing at $787000.0 for Q1 2026.
- In Q1 2026, Receivables fell 61.5% year-over-year to $787000.0; the TTM figure through Mar 2026 stood at $787000.0 (down 61.5% YoY), while the FY2025 annual figure was $1.2 million, down 68.02% from the prior year.
- Receivables for Q1 2026 stood at $787000.0, down from $1.2 million in the prior quarter.
- The five-year high for Receivables was $77.5 million in Q1 2024, with the low at $787000.0 in Q1 2026.
- The 4-year median for Receivables is $3.7 million (2024), against an average of $9.1 million.
- The sharpest annual moves came in 2024 and 2025: Receivables soared 1130.97% in 2024, then tumbled 97.36% in 2025.
- Entrada Therapeutics' Receivables stood at $5.9 million in 2023, then tumbled by 37.39% to $3.7 million in 2024, then plunged by 68.02% to $1.2 million in 2025, then sank by 33.14% to $787000.0 in 2026.
- Business Quant data shows TRDA's Receivables at $787000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Entrada Therapeutics | 290.47 Mn | 290.47 Mn | - | 816,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 816,000.00 |
| Mar 31, 2026 | 787,000.00 |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 77.51 Mn |
| Dec 31, 2023 | 5.88 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 3.74 Mn |
| Mar 31, 2023 | 6.30 Mn |